Xpert MTB宿主反应检测在结核低流行高资源地区改善肺外及少菌肺结核检出
在瑞典斯德哥尔摩前瞻性纳入307例疑似结核病患者,平行进行静脉与毛细血管Xpert MTB宿主反应(MTB-HR)检测。MTB-HR在微生物学确诊肺结核(AUC 0.84)与肺外结核(AUC 0.82)中表现相当,阴性预测值在PCR阴性肺结核为94%、肺外结核为95%。作者建议采用分级MTB-HR评分而非二分类结果。
要点
- MTB-HR在确诊肺结核与肺外结核中AUC分别为0.84与0.82,表现相当。
- PCR阴性肺结核与肺外结核的阴性预测值分别为94%与95%。
- 静脉与毛细血管样本MTB-HR评分高度相关(r=0.97,P<.001)。
核心结论
- 毛细血管Xpert MTB-HR改善痰PCR阴性、培养确诊肺结核的检出,并有望作为肺外结核的排除试验。
- MTB-HR评分与细菌负荷高度相关,作者建议采用分级MTB-HR评分,认为比二分类结果更具临床相关性。
研究设计与样本
- 前瞻性纳入瑞典斯德哥尔摩疑似结核病患者307例,平行进行MTB-HR静脉与毛细血管检测。
- 临床特征基于症状、微生物学结果(镜检、聚合酶链反应[PCR]和培养)、影像学评估及一组生化检测。
- 采用受试者工作特征分析计算最大敏感性与特异性的截断值,包括WHO筛查与诊断试验目标。
主要发现
- MTB-HR在微生物学确诊肺结核(AUC 0.84 [95%CI .78-.90];n=69)与肺外结核(AUC 0.82 [95%CI .75-.90];n=34)中表现相当。
- 基于Youden指数截断值,PCR阴性肺结核(截断值-1.27,NPV 94%)与肺外结核(截断值-1.58,NPV 95%)的阴性预测值均高,并满足确诊肺外结核的最低目标产品概况敏感性要求。
- 无结核个体(n=204)中多数有肺部感染。
- 静脉与毛细血管样本间相关性接近完美(r=0.97,P<.001)。
关键数值与推荐
- 确诊肺结核AUC 0.84(95%CI .78-.90;n=69)。
- 肺外结核AUC 0.82(95%CI .75-.90;n=34)。
- PCR阴性肺结核截断值-1.27,NPV 94%。
- 肺外结核截断值-1.58,NPV 95%。
- 静脉与毛细血管样本相关性r=0.97,P<.001。
临床怎么用
- 作者建议采用分级MTB-HR评分而非二分类结果,认为更具临床相关性。
- 毛细血管Xpert MTB-HR改善痰PCR阴性、培养确诊肺结核的检出,并有望作为肺外结核的排除试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Xpert MTB Host Response (MTB-HR) assay has reached World Health Organization (WHO) test targets for pulmonary tuberculosis (PTB) with high bacillary loads. We investigated the contribution of MTB-HR as a nonsputum, near point-of-care diagnostic method in other prioritized groups, such as extrapulmonary tuberculosis (EPTB) and paucibacillary PTB. METHODS: Individuals with presumed tuberculosis disease were prospectively included in Stockholm, Sweden (n = 307), and underwent MTB-HR venous and capillary testing in parallel. Clinical characterization was based on symptoms, microbiological results (microscopy, polymerase chain reaction [PCR], and culture), radiological assessment, and a panel of biochemical tests. Receiver operating characteristic analysis was performed to calculate cut-offs for maximized sensitivity and specificity, including WHO targets for screening and diagnostic tests. RESULTS: MTB-HR performed equally well in microbiologically confirmed PTB (area under the curve [AUC], 0.84 [95% confidence interval {CI}, .78-.90]; n = 69) and EPTB (AUC, 0.82 [95% CI, .75-.90]; n = 34). Based on Youden index cut-offs, the negative predictive value (NPV) was high both in PCR-negative PTB (-1.27, NPV 94%) and in EPTB (-1.58, NPV 95%) and fulfilled the minimum target product profile sensitivity requirement for confirmed EPTB. In individuals without tuberculosis (n = 204), the majority had pulmonary infections. There was a close to perfect correlation between venous and capillary samples (r = 0.97, P < .001). CONCLUSIONS: Capillary Xpert MTB-HR improves detection of sputum PCR-negative, culture-verified PTB and is promising as a rule-out test in EPTB. MTB-HR score and bacterial burden were highly correlated. We suggest a graded MTB-HR score as more clinically relevant than a binary result.
引用
- Folkesson E, Fröberg G, Sundling C, et al. Improved Detection of Extrapulmonary and Paucibacillary Pulmonary Tuberculosis by Xpert MTB Host Response in a Tuberculosis Low-Endemic, High-Resource Setting. J Infect Dis. 2025. PMID: 40044585. doi:10.1093/infdis/jiaf110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。